Want to know what's happening next in healthcare?

MedCityNews is the leading online news source for the business of innovation in healthcare.


“I find MedCity News a great resource for taking the pulse of the market and sourcing potential investment opportunities.”

Bernie Rudnick, Angel investor and advisor, CapGenic Advisors, LLC


Sign up for our daily newsletter


Case Western Reserve establishes $20M biomedical endowment

10:02 am by | 0 Comments

CWRU President Barbara R. Snyder and Coulter Foundation's Sue Van

Case Western Reserve University and the Wallace H. Coulter Foundation have created a $20 million endowment that’s aimed at translating biomedical research into commercial products and clinical practices.

The creation of the endowment will allow Case’s translational research program funded by the Coulter Foundation to continue in perpetuity. The program was created in 2006 with a $4.8 million grant from the Coulter Foundation to Case, according to a statement from the university.

The program at Case  has helped launch six startup companies and has funded 62 translational research projects. Examples include projects involving the development of advanced imaging technology techniques and thermally-stable insulin.

Advertisement

Case was one of just six U.S. universities to receive the endowment funding from Coulter. The others are Drexel University, Duke University, University of Michigan, Stanford University and University of Virginia.

The Coulter grants work differently than those from the National Institutes of Health and other federal research agencies, more closely resembling a business model, according to Jeffrey Duerk, chairman of biomedical engineering at Case.

““The projects have quarterly milestones and can be shelved by the oversight committee if milestones are not met,” he said. “With the Coulter process, there is strong emphasis on the successful transfer to commercialization.”

The late Wallace H. Coulter, benefactor of the foundation that bears his name, was a serial innovator and entrepreneur. He founded Miami, Florida-based medical diagnostics company Coulter Corporation, now part of Beckman Coulter (NYSE:BEC).

Coulter Corporation developed several innovations for hematology and laboratory medicine, including the Coulter Principle, a method for counting and sizing microscopic particles suspended in fluid that led to automation and quick analysis of complete blood counts.

Copyright 2014 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Brandon Glenn

By Brandon Glenn MedCity News

Brandon Glenn is the Ohio bureau chief for MedCity News.
More posts by Author

0 comments